Target Hospitality (TH) – FDA
-
Theratechnologies (THTX) Announces Publication in Frontiers in Oncology Journal Highlighting SORT1+ Technology for Targeting SORT1-Mediated Vasculogenic Mimicry
-
Theratechnologies (THTX) Announces New Preclinical Findings for Its Lead Investigational Peptide-Drug Conjugate TH1902 for the Potential Treatment of Metastatic Cancers
-
-
-
Back to TH Stock Lookup